Dual Agonist/Antagonist Modulation of α9-Containing Nicotinic Acetylcholine Receptors by 2-Ammoniumethyl Ethers of Stilbenol and Stilbenol Analogues
Journal of Medicinal Chemistry · 2025
DOI: 10.1021/acs.jmedchem.5c02173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Alessandro Giraudo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Università Degli Studi of Milan, Milano I-20133, Italy. Hauptthemen laut MEDLINE: Receptors, Nicotinic, Nicotinic Antagonists, Nicotinic Agonists, Ethers. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New South Wales Government, National Health and Medical Research Council, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
2-(Cyclohexyldimethylammoniumethyl)ether of 4-stilbenol (2), and its styryl-modified analogues 21 and 22, were identified as lead compounds from a series targeting human α9α10, α9, and α7 nicotinic acetylcholine receptors (nAChRs). Compounds 2 and 21 exhibited potent, and subtype-selective modulation of α9-containing receptors, with low nanomolar IC50 values and dual agonist/antagonist activity in a concentration-dependent manner. In contrast, compound 22 acted as a selective, pure antagonist. Molecular dynamics (MD) simulations of compound 21 supported a concentration-dependent allosteric mechanism, with orthosteric binding at low concentrations and vestibular site interaction at higher levels. In a human monocytic cell line, all three compounds inhibited ATP-induced IL-1β release at nanomolar concentrations. These findings identify α9α10-selective ligands as promising scaffolds for the development of nonopioid analgesics and immunomodulators, with favorable selectivity over α7 nAChRs to minimize CNS-related side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Università Degli Studi of Milan, Milano I-20133, Italy.
- Molecular Horizons, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia.
- School of Science, STEM College, RMIT University, Melbourne, Victoria 3001, Australia.
- Department of General and Thoracic Surgery, Laboratory of Experimental Surgery, Justus-Liebig-University, German Center for Lung Research [DZL], Cardio-Pulmonary Institute [CPI], Giessen 35385, Germany.
- Department of Natural Sciences, Bonn-Rhein-Sieg University of Applied Sciences, Rheinbach 53359, Germany.
- Physical and Materials Chemistry Division, CSIR-National Chemical Laboratory, Pune 41108, India.
ORCID-Profile: Alessandro Giraudo, Han-Shen Tae, Marco Pallavicini, David J Adams, Cristiano Bolchi
Förderung
- New South Wales Government
- National Health and Medical Research Council
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Giraudo, A., Tae, H. S., Hung, A., Richter, K., Shivankar, B., Armano, E., Grau, V., Pallavicini, M., Adams, D. J., & Bolchi, C. (2025). Dual Agonist/Antagonist Modulation of α9-Containing Nicotinic Acetylcholine Receptors by 2-Ammoniumethyl Ethers of Stilbenol and Stilbenol Analogues. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02173
Vancouver
Giraudo A, Tae HS, Hung A, Richter K, Shivankar B, Armano E, et al. Dual Agonist/Antagonist Modulation of α9-Containing Nicotinic Acetylcholine Receptors by 2-Ammoniumethyl Ethers of Stilbenol and Stilbenol Analogues. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c02173
BibTeX
@article{Giraudo2025,
author = {Giraudo, Alessandro and Tae, Han-Shen and Hung, Andrew and Richter, Katrin and Shivankar, Bhavana and Armano, Edoardo and Grau, Veronika and Pallavicini, Marco and Adams, David J and Bolchi, Cristiano},
title = {Dual Agonist/Antagonist Modulation of α9-Containing Nicotinic Acetylcholine Receptors by 2-Ammoniumethyl Ethers of Stilbenol and Stilbenol Analogues},
journal = {Journal of Medicinal Chemistry},
year = {2025},
doi = {10.1021/acs.jmedchem.5c02173}
}
EUVIMED